Cell line name | MOR/0.2R |
---|---|
Accession | CVCL_2126 |
Resource Identification Initiative | To cite this cell line use: MOR/0.2R (RRID:CVCL_2126) |
Comments | Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). |
Disease | Lung adenocarcinoma (NCIt: C3512) |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy | Parent: CVCL_2618 (MOR) |
Sex of cell | Sex unspecified |
Age at sampling | Age unspecified |
Category | Cancer cell line |
Publications | PubMed=7903701; DOI=10.1093/jnci/86.2.110 |
Cross-references | |
Cell line collections | ECACC; 96042335 |
Ontologies | CLO; CLO_0007833 |
Other | Wikidata; Q54906389 |